A University of Iowa (UI) spin-out company developing a drug-delivering mechanism to prevent the onset of post-traumatic osteoarthritis recently earned second place—and $25,000—in the 2019 John Pappajohn Iowa Entrepreneurial Venture Competition. CartilaGen, which licensed university intellectual property through the UI Research Foundation (UIRF), focuses on preventative therapies for the onset of...

University of Iowa affiliated companies Behavioral Diagnostics and CartilaGen are two of a dozen emerging startup companies selected to compete at the Partnering for Growth’s Biotech Innovation Showcase on March 21 in Ankeny, Iowa. The companies selected represent a cross section of biotech industry including agricultural technology, human health, animal health and bio materials.

CartilaGen LLC, a University of Iowa spin-out company developing innovative treatments for knee osteoarthritis (OA), recently placed first and second in three different business competitions for Chinese investors in Boston and New York City.